Max Robotics — Global Service Robot Directory + US Certification

About

Samer AlMasri is a pioneering surgeon-researcher at the forefront of robotic pancreatic surgery, whose work is reshaping the landscape of minimally invasive pancreaticoduodenectomy (MI-PD). His research focuses on comparing robotic and laparoscopic approaches for complex pancreatic and ampullary diseases, with a particular emphasis on improving patient outcomes and reducing postoperative complications. AlMasri’s most cited study (2022, 38 citations) demonstrates that robotic pancreaticoduodenectomy (RPD) offers superior outcomes over laparoscopic PD, including lower complication rates and increased adoption. He has also made critical contributions to managing intra-operative challenges, such as hemorrhage and safe venous resection, providing techniques that avoid open conversion (2023, 6 citations). His innovative work extends to biotissue curricula, showing that simulation training translates directly to improved operative performance for gastrojejunostomy and hepaticojejunostomy in RPD (2024). AlMasri’s research on robotic approaches for benign, premalignant, and technically challenging pancreatic head cancers (2021-2022) has established new benchmarks for safety and efficacy. With a growing citation impact, his work is essential reading for surgeons and trainees seeking to master advanced robotic techniques and improve surgical care for pancreatic disease.